Strategies to Increase the Use of Autogenous Arteriovenous Fistula in End-Stage Renal Disease

1997 ◽  
Vol 11 (4) ◽  
pp. 397-405 ◽  
Author(s):  
A. Miller ◽  
T.J. Hölzenbein ◽  
M.N. Gottlieb ◽  
B.A. Sacks ◽  
P.T. Lavin ◽  
...  
Keyword(s):  
Renal Disease ◽  
Arteriovenous Fistula ◽  
End Stage Renal Disease ◽  
Stage Renal Disease ◽  
End Stage

Clinical Considerations in Hemodialysis Access Intervention

2018 ◽  
pp. 594-614
Author(s):  
Eric K. Hoffer
Keyword(s):  
Renal Disease ◽  
Arteriovenous Fistula ◽  
End Stage Renal Disease ◽  
Morbidity And Mortality ◽  
Dialysis Access ◽  
Hemodialysis Access ◽  
National Kidney Foundation ◽  
Clinical Considerations ◽  
Stage Renal Disease ◽  
End Stage

Interventional radiologists developed and refined the endovascular approaches to maintenance of the permanent arteriovenous vascular accesses that are integral to the provision of hemodialysis for patients with end stage renal disease. As methods of percutaneous arteriovenous fistula creation expand the scope of IR, this chapter reviews the clinical indications and preferences pertinent to dialysis access creation with respect to National Kidney Foundation Recommendations. Accesses remain imperfect, plagued by the development of flow-limiting intimal hyperplastic stenoses, and require monitoring and maintenance to minimize complications, morbidity and mortality. The measures of dialysis access function used in the surveillance of vascular accesses that indicate potential stenosis, and the utility of pre-occlusion recanalization of these stenoses are discussed. Complications specific to dialysis access interventions are also addressed.

Plasma D‐Dimer Level and the Failure of Forearm Autologous Arteriovenous Fistula in Patients With End‐Stage Renal Disease

2019 ◽  
Vol 24 (4) ◽  
pp. 400-407
Author(s):  
Jing Du ◽  
Xianglei Kong ◽  
Liming Liang ◽  
Qinlan Chen ◽  
Lili Yin ◽  
...  
Keyword(s):  
Renal Disease ◽  
Arteriovenous Fistula ◽  
End Stage Renal Disease ◽  
Stage Renal Disease ◽  
End Stage ◽  
D Dimer

Predictive Factors for Unsuccessful Use of Arteriovenous Fistula in a Population of End-Stage Renal Disease Patients in Southeastern Mexico

2020 ◽  
Vol 62 ◽  
pp. 304-309
Author(s):  
Gustavo Martinez-Mier ◽  
Cecilia Camargo-Diaz ◽  
Marco Antonio Urbina-Velazquez ◽  
Sandro Fabricio Avila-Pardo
Keyword(s):  
Renal Disease ◽  
Arteriovenous Fistula ◽  
Predictive Factors ◽  
End Stage Renal Disease ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals Comparison of regional and local anesthesia for arteriovenous fistula creation in end-stage renal disease: a systematic review and meta-analysis

2020 ◽  
Author(s):  
Chen Gao ◽  
Chunyan Weng ◽  
Chenghai He ◽  
Jingli Xu ◽  
Liqiang Yu
Keyword(s):  
Systematic Review ◽  
Renal Disease ◽  
Arteriovenous Fistula ◽  
Local Anesthesia ◽  
End Stage Renal Disease ◽  
Meta Analysis ◽  
Primary Patency ◽  
Post Operative Pain ◽  
Stage Renal Disease ◽  
End Stage

Abstract Background Arteriovenous fistulae (AVF) are the hemodialysis access modality of choice for patients with end-stage renal disease. However, they have a high early failure rate. Good vascular access is essential to manage long-term hemodialytic treatment, but some anesthesia techniques directly affect venous diameter as well as intra- and post- operative blood flow. The main purpose of this meta-analysis was to compare the results of regional and local anesthesia for arteriovenous fistula creation in end-stage renal disease.Methods: We conducted a systematic review and meta-analysis to synthesize evidence from 7 randomized controlled trials (565 patients) and 2 observational studies (524 patients) aim to evaluate the safety and efficacy of regional anesthesia (RA) versus local anesthesia (LA) in AVF surgical construction.Results: Pooled data showed that RA was associated with higher primary patency rates than LA (odds ratio [OR], 1.88; 95% confidence interval [CI], 1.24 - 2.84; P = 0.003; I 2 = 31%; Figure 2a). Additionally, brachial artery diameter was significantly increased in the RA versus LA group (mean difference [MD] = 0.83; 95% CI: 0.75 - 0.92; P < 0.001; I 2 = 97%) and the need for intra- as well as post- operative pain killers was significantly less (RA, p = 0.0363; LA, p = 0.0318). Moreover, operation duration was significantly reduced in the RA (67.5 ± 8.9 min) versus LA (134.7 ± 14.8 min) group (p = 0.0007).Conclusions: In conclusion, compared with LA, RA shows higher primary patency rates and it also associated with significantly better intra- as well as post- operative pain control, reduced operative times, which are extremely important in patients with end-stage renal disease and severe comorbidities.

scholarly journals Predictive parameters of arteriovenous fistula maturation in patients with end-stage renal disease

2018 ◽  
Vol 37 (3) ◽  
pp. 277-286 ◽  
Author(s):  
Muhammad A. Siddiqui ◽  
Suhel Ashraff ◽  
Derek Santos ◽  
Robert Rush ◽  
Thomas Carline ◽  
...  
Keyword(s):  
Renal Disease ◽  
Arteriovenous Fistula ◽  
End Stage Renal Disease ◽  
Predictive Parameters ◽  
Stage Renal Disease ◽  
End Stage ◽  
Fistula Maturation ◽  
Arteriovenous Fistula Maturation
Sign in / Sign up

Export Citation Format

Share Document